dyslipidemia
美 
英
例句
HbA1c, aging, dyslipidemia, insulin resistance are found to be significant independent risk factors of carotid atherosclerosis.
糖基化血红蛋白、增龄、血脂异常、胰岛素抵抗是颈动脉粥样硬化的重要因素。
To analyze the correlation between the main syndrome elements of T2DM with dyslipidemia patients and physical and biochemical indexes.
分析T2DM合并血脂异常人群主要证候要素与理化指标之间的关系。
Other risk factors are smoking, dyslipidemia, proteinuria, glomerular hyperfiltration and dietary factors.
其他的风险因素包括：吸烟、血脂异常、蛋白尿、肾小球高滤过和饮食因素。
Results the main risk factors of DN are disease producing pattern, hypertension, hyperglycemia and dyslipidemia.
结果DN危险因素主要有不良生活方式、高血压、高血糖及血脂异常等。
Besides, CHD is a high risk factor to cause ischemic stroke and dyslipidemia is to hemorrhagic stroke for the elder age group.
此外，冠心病对缺血性卒中的危险性大，血脂异常对高年龄人群的出血性卒中危险更大。
The acute mania cohort also had a higher prevalence of dyslipidemia and diabetes, he added.
他指出，急性躁症世代的血脂异常和糖尿病盛行率也较高。
To analyze the directory effect of systematic methodology principle in prophylaxis and treatment of dyslipidemia.
分析系统思维方法主要基本原则在血脂异常综合防治中的指导性作用。
The strategies are reviewed for various types of dyslipidemia in various stages of chronic kidney disease in this paper.
本文对不同阶段的慢性肾脏疾病病人在各种血脂异常时的调脂治疗策略作一综述。
Both body mass index and dyslipidemia were independently relevant with chronic inflammation in PD patients.
而身体质量指数及血脂异常与腹膜透析病患的慢性炎症有明显相关。
And the group of dyslipidemia had more number, severe and diffuse vascular plagues than those of normal lipidemia.
其中血脂异常者和血脂正常者相比，血管病变的数目更多，程度更重，范围更弥漫。
Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD).
慢性肾脏病（CKD）患者动脉高血压和血脂异常。
But the number of dyslipidemia patients reaching lipid goals is low in the clinic.
但在临床实践中，血脂异常病人的真正达标率却还很低。
What is the relationship between isolated post prandial dyslipidemia and the risk of cardiovascular events in diabetic patients?
那么如何看待糖尿病患者单纯餐后血脂异常与心血管事件风险的相关？
The results were not modified by initial folate status, MTHFR C677T genotype, dyslipidemia, or self-reported vascular disease.
结果没有被最初的叶酸状况、MTHFRC677T基因型、脂血或self-reported血管疾病所修饰。
Conclusion Dyslipidemia exists in the IFG patients.
结论新诊断的IFG患者已经存在血脂代谢异常。
International Diabetes: How does insulin resistance affect the development of dyslipidemia?
《国际糖尿病》：胰岛素抵抗如何对血脂产生影响？
Conclusion: Jiangzhi Huoxue Yin had definited regulatory effect on the blood lipids and clinical symptom in patients with dyslipidemia.
结论：降脂活血饮对痰瘀互结证血脂异常患者的临床症状及血脂有一定的调理作用。
Therefore, those who have dyslipidemia, but also for lowering therapy.
因此有血脂紊乱者，还应进行调脂治疗。
Objective: To study the regulatory effect of compound Jiangzhi Huoxue Yin on blood lipids in patients with primary dyslipidemia.
目的：探讨降脂活血饮对痰瘀互结证血脂异常的调节作用。
Nuclear receptors in lipid metabolism: targeting the heart of dyslipidemia
脂类代谢中的核受体：血脂障碍的心脏靶向作用
Clinical study of pravastatin in treatment of dyslipidemia after renal transplantation
普伐他汀治疗肾移植术后血脂异常的临床研究
Clinical efficacy of an intensive atorvastatin therapy in coronary heart disease patients with dyslipidemia
阿托伐他汀强化治疗冠心病患者血脂异常的临床疗效
Study of the Therapy Effects of Low-intensity Laser Rhinal Radiation on Dyslipidemia
低强度激光鼻腔照射对血脂异常作用的研究
New recognition of a role of dyslipidemia and lipid-lowing treatment in pathogenesis of renal disease
对肾脏疾病中脂质异常与降脂治疗作用的新认识
Comparative study on prevalence rate of dyslipidemia among Korean-Chinese nationality and Han nationality
朝鲜族及汉族居民血脂异常分布特征比较研究
Therapy Modifications in Response to Poorly Controlled Hypertension, Dyslipidemia, and Diabetes Mellitus
针对控制不良的高血压、血脂紊乱和糖尿病的治疗修正
Clinical observation of relativity between cerebral infarction and dyslipidemia in patients with diabetes mellitus
糖尿病合并脑梗死与血脂异常相关性的临床观察
Dyslipidemia and the cardiovascular complications in patients with maintaining hemodialysis
血脂代谢紊乱与维持性血液透析患者的心血管并发症
Analysis of dyslipidemia, fatty liver and elevated glutamate-pyruvate transaminase of in-hospital aircraft pilots
住院军队飞行人员血脂异常脂肪肝和谷丙转氨酶升高的分析
Analyzing Dyslipidemia of Coronary Heart Disease by Capillary Isotachophoresis
毛细管等速电泳法分析冠心病血脂异常
Lipoprotein Lipase Mutation Predisposes Carriers to Severe Dyslipidemia
脂蛋白脂酶变异易产生严重血脂紊乱基因携带者
The Relationship Between Insulin Resistance And dyslipidemia in Coronary Heart Disease Patients
冠心病患者胰岛素抵抗与血脂关系的研究
Study on Clinical Characteristics of the Relationship between Dyslipidemia and hyperglycemia in Patients with Type 2 Diabetes
2型糖尿病患者糖代谢紊乱与脂代谢紊乱关系的临床研究
Repeated oral treatment with polysaccharide sulfate reduces insulin resistance and dyslipidemia in diabetic dyslipidemic rat model
藻酸双酯钠改善模型大鼠的胰岛素抵抗和血脂异常
Nephrotoxicity induced by dyslipidemia in children with primary nephritic syndrome
原发性肾病综合征患儿血脂代谢紊乱的肾毒性作用
Relationship between insulin resistance and dyslipidemia in aged patients with diabetes
老年糖尿病胰岛素抵抗与脂代谢紊乱
The clinic study on the relationship between insulin resistance and dyslipidemia in coronary heart disease
冠心病患者胰岛素抵抗与血脂、载脂蛋白异常的关系
Prevalence of hypertension, diabetes and dyslipidemia of the survey population (over 15 years old) was 18. 5%, 4. 0% and 6. 3% respectively.
监测人群中15岁及以上成年人高血压、糖尿病、血脂异常患病率依次为18.5%、4.0%和6.
Survey of plasma lipid value in children in Beijing area and the changes of gaseous molecule-hydrogen sulfide in the ones with dyslipidemia
北京地区部分儿童血脂现状调查及气体分子硫化氢在血脂紊乱中的变化
Relationship between polymorphism of microsomal triglyceride transfer protein gene and dyslipidemia in type 2 diabetics
微粒体甘油三酯转移蛋白基因多态性与2型糖尿病血脂紊乱的关系
